193 related articles for article (PubMed ID: 6094649)
1. The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis.
Caniggia A; Nuti R; Loré F; Vattimo A
J Endocrinol Invest; 1984 Aug; 7(4):373-8. PubMed ID: 6094649
[TBL] [Abstract][Full Text] [Related]
2. Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis.
Riggs BL; Nelson KI
J Clin Endocrinol Metab; 1985 Sep; 61(3):457-61. PubMed ID: 3926808
[TBL] [Abstract][Full Text] [Related]
3. Prevention of bone mineral loss in postmenopausal women by norethisterone.
Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
[TBL] [Abstract][Full Text] [Related]
4. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.
Need AG; Horowitz M; Philcox JC; Nordin BE
Miner Electrolyte Metab; 1985; 11(1):35-40. PubMed ID: 3838358
[TBL] [Abstract][Full Text] [Related]
6. Effects of norethisterone on bone related biochemical variables and forearm bone mineral in post-menopausal osteoporosis.
Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
Clin Endocrinol (Oxf); 1993 Dec; 39(6):649-55. PubMed ID: 8287582
[TBL] [Abstract][Full Text] [Related]
7. Effects of a short course of estrogen on mineral metabolism in postmenopausal women.
Stock JL; Coderre JA; Mallette LE
J Clin Endocrinol Metab; 1985 Oct; 61(4):595-600. PubMed ID: 2993339
[TBL] [Abstract][Full Text] [Related]
8. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
Need AG; Morris HA; Hartley TF; Horowitz M; Nordin BE
Calcif Tissue Int; 1987 Jul; 41(1):7-10. PubMed ID: 3113703
[TBL] [Abstract][Full Text] [Related]
9. Biochemical effects of calcium supplementation in postmenopausal osteoporosis.
Horowitz M; Need AG; Morris HA; Wishart J; Nordin BE
Eur J Clin Nutr; 1988 Sep; 42(9):775-8. PubMed ID: 3181110
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
Koev D; Todorova S; Diankov L; Khristova D; Tsachev K
Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094
[TBL] [Abstract][Full Text] [Related]
11. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.
Lawoyin S; Zerwekh JE; Glass K; Pak CY
J Clin Endocrinol Metab; 1980 Mar; 50(3):593-6. PubMed ID: 6965678
[TBL] [Abstract][Full Text] [Related]
12. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
Christiansen C; Rødbro P; Tjellesen L
Acta Med Scand; 1984; 216(1):11-7. PubMed ID: 6385631
[TBL] [Abstract][Full Text] [Related]
13. 1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.
Gallagher JC; Jerpbak CM; Jee WS; Johnson KA; DeLuca HF; Riggs BL
Proc Natl Acad Sci U S A; 1982 May; 79(10):3325-9. PubMed ID: 6954482
[TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis.
Matsumoto T; Ezawa I; Morita K; Kawanobe Y; Ogata E
J Nutr Sci Vitaminol (Tokyo); 1985 Dec; 31 Suppl():S61-5. PubMed ID: 3915757
[TBL] [Abstract][Full Text] [Related]
15. Reduction in intestinal calcium absorption by hydrochlorothiazide in postmenopausal osteoporosis.
Sakhaee K; Nicar MJ; Glass K; Zerwekh JE; Pak CY
J Clin Endocrinol Metab; 1984 Dec; 59(6):1037-43. PubMed ID: 6490791
[TBL] [Abstract][Full Text] [Related]
16. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women.
Horowitz M; Need AG; Philcox JC; Nordin BE
Horm Metab Res; 1985 Jun; 17(6):311-2. PubMed ID: 4018720
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D stimulation test for osteoblast function in normal and osteoporotic postmenopausal women.
Duda RJ; Kumar R; Nelson KI; Zinsmeister AR; Mann KG; Riggs BL
J Clin Invest; 1987 Apr; 79(4):1249-53. PubMed ID: 3494046
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral and calcium metabolism before, during and after treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
Lindholm TS; Eriksson S
Scand J Rheumatol; 1982; 11(1):55-7. PubMed ID: 7063813
[TBL] [Abstract][Full Text] [Related]
20. Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss?
Riis BJ; Thomsen K; Christiansen C
Calcif Tissue Int; 1986 Sep; 39(3):128-32. PubMed ID: 3093022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
